nach oben

NeuroMolecular Medicine

Erschienen in:

01.09.2008 | Review Paper

Neurotrophic Factors in Autonomic Nervous System Plasticity and Dysfunction

verfasst von: Mark P. Mattson, Ruiqian Wan

Erschienen in: NeuroMolecular Medicine | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

During development, neurotrophic factors are known to play important roles in regulating the survival of neurons in the autonomic nervous system (ANS) and the formation of their synaptic connectivity with their peripheral targets in the cardiovascular, digestive, and other organ systems. Emerging findings suggest that neurotrophic factors may also affect the functionality of the ANS during adult life and may, in part, mediate the effects of environmental factors such as exercise and dietary energy intake on ANS neurons and target cells. In this article, we describe the evidence that ANS neurons express receptors for multiple neurotrophic factors, and data suggesting that activation of those receptors can modify plasticity in the ANS. Neurotrophic factors that may regulate ANS function include brain-derived neurotrophic factor, nerve growth factor, insulin-like growth factors, and ciliary neurotrophic factor. The possibility that perturbed neurotrophic factor signaling is involved in the pathogenesis of ANS dysfunction in some neurological disorders is considered, together with implications for neurotrophic factor-based therapeutic interventions.

Aharon-Peretz, J., Harel, T., Revach, M., & Ben-Haim, S. A. (1992). Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer’s disease. Archives of Neurology, 49, 919–922PubMed

Ahmet, I., Wan, R., Mattson, M. P., Lakatta, E. G., & Talan, M. (2005). Cardioprotection by intermittent fasting in rats. Circulation, 112, 3115–3121.PubMed

Airaksinen, M. S., Holm, L., & Hatinen, T. (2006). Evolution of the GDNF family ligands and receptors. Brain Behavior and Evolution, 68, 181–190.

Algotsson, A., Viitanen, M., Winblad, B., & Solders, G. (1995). Autonomic dysfunction in Alzheimer’s disease. Acta Neurologica Scandinavica, 91, 14–18.PubMed

Allan, L. M., Ballard, C. G., Allen, J., Murray, A., Davidson, A. W., McKeith, I. G., & Kenny, R. A. (2007). Autonomic dysfunction in dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 671–677.PubMed

Andrich, J., Schmitz, T., Saft, C., Postert, T., Kraus, P., Epplen, J. T., Przuntek, H., & Agelink, M. W. (2002). Autonomic nervous system function in Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 72, 726–731.PubMed

Anitha, M., Gondha, C., Sutliff, R., Parsadanian, A., Mwangi, S., Sitaraman, S. V., & Srinivasan, S. (2006). GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. Journal of Clinical Investigation, 116, 344–356.PubMed

Arsenijevic, Y., & Weiss, S. (1998). Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: Distinct actions from those of brain-derived neurotrophic factor. Journal of Neuroscience, 18, 2118–2128.PubMed

Asai, N., Fukuda, T., Wu, Z., Enomoto, A., Pachnis, V., Takahashi, M., & Costantini, F. (2006). Targeted mutation of serine 697 in the Ret tyrosine kinase causes migration defect of enteric neural crest cells. Development, 133, 4507–4516.PubMed

Awerbuch, G. I., & Sandyk, R. (1994). Autonomic functions in the early stages of Parkinson’s disease. The International Journal of Neuroscience, 74, 9–16.PubMed

Baloh, R. H., Enomoto, H., Johnson, E. M., Jr., & Milbrandt, J. (2000). The GDNF family ligands and receptors—implications for neural development. Current Opinions in Neurobiology, 10, 103–110.

Barbacid, M. (1995). Structural and functional properties of the TRK family of neurotrophin receptors. Annals of the New York Academy of Sciences, 766, 442–458.PubMed

Bariohay, B., Lebrun, B., Moyse, E., & Jean, A. (2005). Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology, 146, 5612–5620.PubMed

Berretta, S. (2005). Cortico-amygdala circuits: Role in the conditioned stress response. Stress, 8, 221–232.PubMedCrossRef

Bharmal, S., Slonimsky, J. D., Mead, J. N., Sampson, C. P., Tolkovsky, A. M., Yang, B., Bargman, R., & Birren, S. J. (2001). Target cells promote the development and functional maturation of neurons derived from a sympathetic precursor cell line. Developmental Neuroscience, 23, 153–164.PubMed

Birkhofer, A., Schmidt, G., & Forstl, H. (2005). Heart and brain—the influence of psychiatric disorders and their therapy on the heart rate variability. Fortschritte der Neurologie-Psychiatrie, 73, 192–205.PubMed

Boesmans, W., Gomes, P., Janssens, J., Tack, J., & Vanden Berghe, P. (2007). Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes synaptic communication in the enteric nervous system. Gut (Epub ahead of print).

Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24, 197–211.PubMed

Braak, H., Sastre, M., Bohl, J. R., de Vos, R. A., & Del Tredici, K. (2007). Parkinson’s disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathologica (Berl), 113, 421–429.

Buj-Bello, A., Buchman, V. L., Horton, A., Rosenthal, A., & Davies, A. M. (1995). GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron, 15, 821–828.PubMed

Causing, C. G., Gloster, A., Aloyz, R., Bamji, S. X., Chang, E., Fawcett, J., Kuchel, G., & Miller, F. D. (1997). Synaptic innervation density is regulated by neuron-derived BDNF. Neuron, 18, 257–267.PubMed

Casscells, W., Speir, E., Sasse, J., Klagsbrun, M., Allen, P., Lee, M., Calvo, B., Chiba, M., Haggroth, L., & Folkman, J. (1990). Isolation, characterization, and localization of heparin-binding growth factors in the heart. Journal of Clinical Investigation, 85, 433–441.PubMed

Chalazonitis, A. (2004). Neurotrophin-3 in the development of the enteric nervous system. Progress in Brain Research, 146, 243–263.PubMed

Cheng, B., & Mattson, M. P. (1991). NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron, 7, 1031–1041.PubMed

Cheng, B., McMahon, D. G., & Mattson, M. P. (1993). Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Research, 607, 275–285.PubMed

Chun, L. L., & Patterson, P. H. (1977). Role of nerve growth factor in the development of rat sympathetic neurons in vitro. I. Survival, growth, and differentiation of catecholamine production. The Journal of Cell Biology, 75, 694–704.PubMed

Claes, S. J. (2004). Corticotropin-releasing hormone (CRH) in psychiatry: From stress to psychopathology. Annals of Medicine, 36, 50–61.PubMed

Collins, F., & Dawson, A. (1983). An effect of nerve growth factor on parasympathetic neurite outgrowth. Proceedings of the National Academy of Sciences of the United States of America, 80, 2091–2094.PubMed

Connor, B., Young, D., Yan, Q., Faull, R. L., Synek, B., & Dragunow, M. (1997). Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Molecular Brain Research, 49, 71–81.PubMed

Cotman, C. W., Berchtold, N. C., & Christie, L. A. (2007). Exercise builds brain health: Key roles of growth factor cascades and inflammation. Trends in Neuroscience, 30, 464–472.

Craddock, N., & Forty, L. (2006). Genetics of affective (mood) disorders. European Journal of Human Genetics, 14, 660–668.PubMed

Crouch, M. F., & Hendry, I. A. (1991). Co-activation of insulin-like growth factor-I receptors and protein kinase C results in parasympathetic neuronal survival. Journal of Neuroscience Research, 28, 115–120.PubMed

Crowell, M. D., & Wessinger, S. B. (2007). 5-HT and the brain-gut axis: Opportunities for pharmacologic intervention. Expert Opinion on Investigational Drugs, 16, 761–765.PubMed

DeRijk, R., & de Kloet, E. R. (2005). Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine, 28, 263–270.PubMed

De Rosa, R., Garcia, A. A., Braschi, C., Capsoni, S., Maffei, L., Berardi, N., & Cattaneo, A. (2005). Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 102, 3811–3816.PubMed

Devos, D., Kroumova, M., Bordet, R., Vodougnon, H., Guieu, J. D., Libersa, C., & Destee, A. (2003). Heart rate variability and Parkinson’s disease severity. Journal of Neural Transmission, 110, 997–1011.PubMed

Dewey, R. B., Jr. (2004). Autonomic dysfunction in Parkinson’s disease. Neurologic Clinics, 22, S127–139.PubMed

DiCicco-Bloom, E., & Black, I. B. (1988). Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts. Proceedings of the National Academy of Sciences of the United States of America, 85, 4066–4070.PubMed

Distasi, C., Torre, M., Antoniotti, S., Munaron, L., & Lovisolo, D. (1998). Neuronal survival and calcium influx induced by basic fibroblast growth factor in chick ciliary ganglion neurons. European Journal of Neuroscience, 10, 2276–2286.PubMed

Doering, L. C., Roder, J. C., & Henderson, J. T. (1995). Ciliary neurotrophic factor promotes the terminal differentiation of v-myc immortalized sympathoadrenal progenitor cells in vivo. Developmental Brain Research, 89, 56–66.PubMed

Dono, R., Texido, G., Dussel, R., Ehmke, H., & Zeller, R. (1998). Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO Journal, 17, 4213–4225.PubMed

Duan, W., Guo, Z., Jiang, H., Ware, M., & Mattson, M. P. (2003a). Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology, 144, 2446–2453.PubMed

Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X. J., & Mattson, M. P. (2003b). Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 100, 2911–2916.PubMed

Ebendal, T., Tomac, A., Hoffer, B. J., & Olson, L. (1995). Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral autonomic ganglia. Journal of Neuroscience Research, 40, 276–284.PubMed

Edgar, D., Barde, Y. A., & Thoenen, H. (1981). Subpopulations of cultured chick sympathetic neurones differ in their requirements for survival factors. Nature 289, 294–295.PubMed

Ekblad, E., & Bauer, A. J. (2004). Role of vasoactive intestinal peptide and inflammatory mediators in enteric neuronal plasticity. Neurogastroenterology and Motility, 16, S123–128.

Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R. O., Snider, W. D., Johnson, E. M., Jr., & Milbrandt, J. (1998). GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron, 21, 317–324.PubMed

Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Reviews, 16, 139–149.PubMed

Ferrer, I., Goutan, E., Marin, C., Rey, M. J., & Ribalta, T. (2000). Brain-derived neurotrophic factor in Huntington disease. Brain Research, 866, 257–261.PubMed

Ferrer, I., Marin, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., & Marti, E. (1999). BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. Journal of Neuropathology and Experimental Neurology, 58, 729–739.PubMed

Francke, U. (2006). Mechanisms of disease: Neurogenetics of MeCP2 deficiency. Nature Clinical Practice Neurology, 2, 212–221.PubMed

Ginsberg, S. D., Che, S., Wuu, J., Counts, S. E., & Mufson, E. J. (2006). Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer’s disease. Journal of Neurochemistry, 97, 475–487.PubMed

Giubilei, F., Strano, S., Imbimbo, B. P., Tisei, P., Calcagnini, G., Lino, S., Frontoni, M., Santini, M., & Fieschi, C. (1998). Cardiac autonomic dysfunction in patients with Alzheimer disease: Possible pathogenetic mechanisms. Alzheimer Disease and Associated Disorders, 12, 356–361.PubMedCrossRef

Gorman, J. M., & Sloan, R. P. (2000). Heart rate variability in depressive and anxiety disorders. American Heart Journal, 40, 77–83.

Halagappa, V. K., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., Laferla, F. M., & Mattson, M. P. (2007). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease. Neurobiology of Disease, 26, 212–220.PubMed

Hasan, W., & Smith, P. G. (2000). Nerve growth factor expression in parasympathetic neurons: Regulation by sympathetic innervation. European Journal of Neuroscience, 12, 4391–4397.PubMed

Hazari, M. S., Pan, J. H., & Myers, A. C. (2007). Nerve growth factor acutely potentiates synaptic transmission in vitro and induces dendritic growth in vivo on adult neurons in airway parasympathetic ganglia. American Journal of Physiology. Lung Cellular and Molecular Physiology, 292, L992–1001.PubMed

Helke, C. J., Adryan, K. M., Fedorowicz, J., Zhuo, H., Park, J. S., Curtis, R., Radley, H. E., & Distefano, P. S. (1998). Axonal transport of neurotrophins by visceral afferent and efferent neurons of the vagus nerve of the rat. The Journal of Comparitive Neurology, 393, 102–117.

Hock, C., Heese, K., Muller-Spahn, F., Hulette, C., Rosenberg, C., & Otten, U. (1998). Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer’s disease. Neuroscience Letters, 241, 151–154.PubMed

Hottenrott, K., Hoos, O., & Esperer, H. D. (2006). Heart rate variability and physical exercise. Current status. Herz, 31, 544–552.PubMed

Hou, R. H., Samuels, E. R., Raisi, M., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (2006). Why patients with Alzheimer’s disease may show increased sensitivity to tropicamide eye drops: Role of locus coeruleus. Psychopharmacology (Berl), 184, 95–106.

Hurelbrink, C. B., & Barker, R. A. (2001). Prospects for the treatment of Parkinson’s disease using neurotrophic factors. Expert Opinion on Pharmacotherapy, 2, 1531–1543.PubMed

Ip, N. Y., Boulton, T. G., Li, Y., Verdi, J. M., Birren, S. J., Anderson, D. J., & Yancopoulos, G. D. (1994). NTF, FGF, and NGF collaborate to drive the terminal differentiation of MAH cells into postmitotic neurons. Neuron, 13, 443–455.PubMed

Johnson, J. B., Summer, W., Cutler, R. G., Martin, B., Hyun, D. H., Dixit, V. D., Pearson, M., Nassar, M., Tellejohan, R., Maudsley, S., Carlson, O., John, S., Laub, D. R., & Mattson, M. P. (2007). Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radical Biology & Medicine, 42, 665–674.

Jordan, D. (2005). Vagal control of the heart: Central serotonergic (5-HT). mechanisms. Experimental Physiology, 90, 175–181.PubMed

Kallio, M., Haapaniemi, T., Turkka, J., Suominen, K., Tolonen, U., Sotaniemi, K., Heikkila, V. P., & Myllyla, V. (2000). Heart rate variability in patients with untreated Parkinson’s disease. European Journal of Neurology, 7, 667–672.PubMed

Karagiannis, S. N., King, R. H., & Thomas, P. K. (1997). Colocalisation of insulin and IGF-1 receptors in cultured rat sensory and sympathetic ganglion cells. Journal of Anatomy, 191, 431–440.PubMed

Kasselman, L. J., Sideris, A., Bruno, C., Perez, W. R., Cai, N., Nicoletti, J. N., Wiegand, S. J., & Croll, S. D. (2006). BDNF: A missing link between sympathetic dysfunction and inflammatory disease? Journal of Neuroimmunology, 175, 118–127.PubMed

Kelly-Spratt, K. S., Klesse, L. J., & Parada, L. F. (2002). BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signaling. Journal of Neuroscience Research, 69, 151–159.PubMed

Kessler, J. A., & Black, I. B. (1980). The effects of nerve growth factor (NGF). and antiserum to NGF on the development of embryonic sympathetic neurons in vivo. Brain Research, 189, 157–168.PubMed

Klimaschewski, L., Meisinger, C., & Grothe, C. (1999). Localization and regulation of basic fibroblast growth factor (FGF-2) and FGF receptor-1 in rat superior cervical ganglion after axotomy. Journal of Neurobiology, 38, 499–506.PubMed

Kobal, J., Meglic, B., Mesec, A., & Peterlin, B. (2004). Early sympathetic hyperactivity in Huntington’s disease. European Journal of Neurology, 11, 842–848.PubMed

Kwon, B. K., Liu, J., Lam, C., Plunet, W., Oschipok, L. W., Hauswirth, W., Di Polo, A., Blesch, A., & Tetzlaff, W. (2007). Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine, 32, 1164–1173.PubMed

Kyrou, I., & Tsigos, C. (2007). Stress mechanisms and metabolic complications. Hormone and Metabolic Research, 39, 430–438.PubMed

Laustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007). Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Molecular Cell Biology, 27, 1649–1664.

Lechin, F., van der Dijs, B., Orozco, B., Lechin, A. E., Baez, S., Lechin, M. E., Rada, I., Acosta, E., Arocha, L., Jimenez, V., et al. (1995). Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients. Biological Psychiatry, 37, 884–891.PubMed

Lee, J., Duan, W., & Mattson, M. P. (2002b). Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. Journal of Neurochemistry, 82, 1367–1375.PubMed

Lee, P. G., Hohman, T. C., Cai, F., Regalia, J., & Helke, C. J. (2001). Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Experimental Neurology, 170, 149–161.PubMed

Lee, J., Seroogy, K. B., & Mattson, M. P. (2002a). Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. Journal of Neurochemistry, 80, 539–547.PubMed

LeVatte, M. A., Dekaban, G. A., & Weaver, L. C. (1997). Gene transfer into sympathetic preganglionic neurons in vivo using a non-replicating thymidine kinase-deficient herpes simplex virus type 1. Neuroscience, 80, 893–906.PubMed

Levi-Montalcini, R., & Calissano, P. (1979). The nerve-growth factor. Scientific American, 240, 44–53.CrossRef

Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. J. (1995). Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson’s disease. Journal of Neuroscience, 15, 7810–7820.PubMed

Lockhart, S. T., Mead, J. N., Pisano, J. M., Slonimsky, J. D., & Birren, S. J. (2000). Nerve growth factor collaborates with myocyte-derived factors to promote development of presynaptic sites in cultured sympathetic neurons. Journal of Neurobiology, 42, 460–476.PubMed

Lockhart, S. T., Turrigiano, G. G., & Birren, S. J. (1997). Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. Journal of Neuroscience, 17, 9573–9582.PubMed

Loewenthal, N., Levy, J., Schreiber, R., Pinsk, V., Perry, Z., Shorer, Z., & Hershkovitz, E. (2005). Nerve growth factor-tyrosine kinase A pathway is involved in thermoregulation and adaptation to stress: Studies on patients with hereditary sensory and autonomic neuropathy type IV. Pediatric Research, 57, 587–590.PubMed

Lynch, G., Kramar, E. A., Rex, C. S., Jia, Y., Chappas, D., Gall, C. M., & Simmons, D. A. (2007). Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington’s disease. Journal of Neuroscience, 27, 4424–4434.PubMed

Mager, D. E., Wan, R., Brown, M., Cheng, A., Wareski, P., Abernethy, D. R., & Mattson, M. P. (2006). Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB Journal, 20, 631–637.PubMed

Malaspina, D., Dalack, G., Leitman, D., Corcoran, C., Amador, X. F., Yale, S., Glassman, A., & Gorman, J. M. (2002). Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectrums, 7, 53–57.PubMed

Martinelli, P. M., Camargos, E. R., Azevedo, A. A., Chiari, E., Morel, G., & Machado, C. R. (2006). Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats. Autonomic Neuroscience, 130, 32–40.PubMed

Martini, G., Riva, P., Rabbia, F., Molini, V., Ferrero, G. B., Cerutti, F., Carra, R., & Veglio, F. (2001). Heart rate variability in childhood obesity. Clinical Autonomic Research, 11, 87–91.PubMed

Martinowich, K., & Lu, B. (2007). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology, 33, 73–83.

Mastrocola, C., Vanacore, N., Giovani, A., Locuratolo, N., Vella, C., Alessandri, A., Baratta, L., Tubani, L., & Meco, G. (1999). Twenty-four-hour heart rate variability to assess autonomic function in Parkinson’s disease. Acta Neurologica Scandinavica, 99, 245–247.PubMed

Maswood, N., Young, J., Tilmont, E., Zhang, Z., Gash, D. M., Gerhardt, G. A., Grondin, R., Roth, G. S., Mattison, J., Lane, M. A., Carson, R. E., Cohen, R. M., Mouton, P. R., Quigley, C., Mattson, M. P., & Ingram, D. K. (2004). Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America, 101, 18171–18176.PubMed

Matsuoka, Y., Gray, A. J., Hirata-Fukae, C., Minami, S. S., Waterhouse, E. G., Mattson, M. P., LaFerla, F. M., Gozes, I., & Aisen, P. S. (2007). Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer’s disease at early pathological stage. Journal of Molecular Neuroscience, 31, 165–170.PubMed

Mattson, M. P., & Cheng, A. (2006). Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends in Neuroscience, 29, 632–639.

Mattson, M. P., Maudsley, S., & Martin, B. (2004). A neural signaling triumvirate that influences ageing and age-related disease: Insulin/IGF-1, BDNF and serotonin. Ageing Research Reviews, 3, 445–464.PubMed

Mattson, M. P., Murrain, M., Guthrie, P. B., & Kater, S. B. (1989). Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitecture. Journal of Neuroscience, 9, 3728–3740.PubMed

Mattson, M. P., & Wan, R. (2005). Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. The Journal of Nutritional Biochemistry, 16, 129–137.PubMed

Mattson, M. P., Zhang, Y., & Bose, S. (1993). Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Experimental Neurology, 121, 1–13.PubMed

Mijatovic, J., Airavaara, M., Planken, A., Auvinen, P., Raasmaja, A., Piepponen, T. P., Costantini, F., Ahtee, L., & Saarma, M. (2007). Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. Journal of Neurosciences, 27, 4799–4809.

Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999). Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson’s disease. Neurosci Letters, 270, 45–48.

Mohan, R. M., Golding, S., Heaton, D. A., Danson, E. J., & Paterson, D. J. (2004). Targeting neuronal nitric oxide synthase with gene transfer to modulate cardiac autonomic function. Progress in Biophysics and Molecular Biology, 84, 321–344.PubMed

Mufson, E. J., Lavine, N., Jaffar, S., Kordower, J. H., Quirion, R., & Saragovi, H. U. (1997). Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer’s disease. Experimental Neurology, 146, 91–103.PubMed

Nakagawa, T., Ono-Kishino, M., Sugaru, E., Yamanaka, M., Taiji, M., & Noguchi, H. (2002). Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Diabetes Metabolism Research Reviews., 18, 185–191.

Neeper, S. A., Gomez-Pinilla, F., Choi, J., & Cotman, C. W. (1996). Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Research, 726, 49–56.PubMed

Nelson, R. L., Guo, Z., Halagappa, V. M., Pearson, M., Gray, A. J., Matsuoka, Y., Brown, M., Martin, B., Iyun, T., Maudsley, S., Clark, R. F., & Mattson, M. P. (2007). Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3×TgAD mice. Experimental Neurology, 205, 166–176.PubMed

Nomura, Y., Kimura, K., Arai, H., & Segawa, M. (1997). Involvement of the autonomic nervous system in the pathophysiology of Rett syndrome. European Child Adolescent Psychiatry, 6, S42–46.

Oka, H., Mochio, S., Onouchi, K., Morita, M., Yoshioka, M., & Inoue, K. (2006). Cardiovascular dysautonomia in de novo Parkinson’s disease. Journal of Neurological Sciences, 241, 59–65.

Parain, K., Murer, M. G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999). Reduced expression of brain-derived neurotrophic factor protein in Parkinson’s disease substantia nigra. Neuroreport, 10, 557–561.PubMed

Paterson, D. S., Thompson, E. G., Belliveau, R. A., Antalffy, B. A., Trachtenberg, F. L., Armstrong, D. D., & Kinney, H. C. (2005). Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in Rett syndrome: potential implications for clinical autonomic dysfunction. Journal of Neuropathology and Experimental Neurology, 64, 1018–1027.PubMed

Peiris, T. S., Machaalani, R., & Waters, K. A. (2004). Brain-derived neurotrophic factor mRNA and protein in the piglet brainstem and effects of intermittent hypercapnic hypoxia. Brain Research, 1029, 11–23.PubMed

Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron, 7, 695–702.PubMed

Puri, P., & Shinkai, T. (2004). Pathogenesis of Hirschsprung’s disease and its variants: Recent progress. Seminars in Pediatric Surgery, 13, 18–24.PubMed

Pursiainen, V., Korpelainen, J. T., Huikuri, H. V., Sotaniemi, K. A., & Myllyla, V. V. (2002). Circadian heart rate variability in Parkinson’s disease. Journal of Neurology, 249, 1535–1540.PubMed

Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society of London Series B Biological Sciences, 361, 1545–1564.

Reimer, M. K., Mokshagundam, S. P., Wyler, K., Sundler, F., Ahren, B., & Stagner, J. I. (2003). Local growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats. Pancreas, 26, 392–397.PubMed

Reiss, K., Kajstura, J., Zhang, X., Li, P., Szoke, E., Olivetti, G., & Anversa, P. (1994). Acute myocardial infarction leads to upregulation of the IGF-1 autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. Experimental Cell Research, 213, 463–472.PubMed

Roosen, A., Schober, A., Strelau, J., Bottner, M., Faulhaber, J., Bendner, G., McIlwrath, S. L., Seller, H., Ehmke, H., Lewin, G. R., & Unsicker, K. (2001). Lack of neurotrophin-4 causes selective structural and chemical deficits in sympathetic ganglia and their preganglionic innervation. Journal of Neuroscience, 21, 3073–3084.PubMed

Rosenwinkel, E. T., Bloomfield, D. M., Arwady, M. A., & Goldsmith, R. L. (2001). Exercise and autonomic function in health and cardiovascular disease. Cardiology Clinics, 19, 369–387.PubMed

Rossi, J., Herzig, K. H., Voikar, V., Hiltunen, P. H., Segerstrale, M., & Airaksinen, M. S. (2003). Alimentary tract innervation deficits and dysfunction in mice lacking GDNF family receptor alpha2. Journal of Clinical Investigation, 112, 707–716.PubMed

Sariola, H., & Saarma, M. (2003). Novel functions and signalling pathways for GDNF. Journal of Cell Science, 116, 3855–3862.PubMed

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Nakanishi, M., Akaike, A., & Shimohama, S. (2000). Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons. Journal of Neurochemistry, 74, 1175–1184.PubMed

Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Parvin, C. A., & Escandon, E. (2001). Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy. Journal of Neuropathology and Experimantal Neurology, 60, 263–273.

Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Plurad, S. B., Parvin, C. A., & Miller, M. S. (1999). Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. American Journal of Pathology, 155, 1651–1660.PubMed

Schober, A., Minichiello, L., Keller, M., Huber, K., Layer, P. G., Roig-Lopez, J. L., Garcia-Arraras, J. E., Klein, R., & Unsicker, K. (1997). Reduced acetylcholinesterase (AChE) activity in adrenal medulla and loss of sympathetic preganglionic neurons in TrkA-deficient, but not TrkB-deficient, mice. Journal of Neuroscience, 17, 891–903.PubMed

Schober, A., Wolf, N., Huber, K., Hertel, R., Krieglstein, K., Minichiello, L., Kahane, N., Widenfalk, J., Kalcheim, C., Olson, L., Klein, R., Lewin, G. R., & Unsicker, K. (1998). TrkB and neurotrophin-4 are important for development and maintenance of sympathetic preganglionic neurons innervating the adrenal medulla. Journal of Neuroscience, 18, 7272–7284.PubMed

Silani, V., Borasio, G. D., Zhou, F. C., Bernasconi, S., Pizzuti, A., Sampietro, A., & Scarlato, G. (1994). NGF-response of EGF-dependent progenitor cells obtained from human sympathetic ganglia. Neuroreport, 5, 2085–2089.PubMed

Sleeman, M. W., Anderson, K. D., Lambert, P. D., Yancopoulos, G. D., & Wiegand, S. J. (2000). The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharmaceutica Acta Helvetiae, 74, 265–272.PubMed

Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R., Chebrolu, H., Walton, A., Wagner, R., & Young, A. B. (2007). Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. Journal of Neurosurgery, 106, 614–620.PubMed

Slonimsky, J. D., Yang, B., Hinterneder, J. M., Nokes, E. B., & Birren, S. J. (2003). BDNF and CNTF regulate cholinergic properties of sympathetic neurons through independent mechanisms. Molecular and Cellular Neuroscience, 23, 648–660.PubMed

Speir, E., Tanner, V., Gonzalez, A. M., Farris, J., Baird, A., & Casscells, W. (1992). Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circulation Research, 71, 251–259.PubMed

Spires, T. L., Grote, H. E., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C., & Hannan, A. J. (2004). Environmental enrichment rescues protein deficits in a mouse model of Huntington’s disease, indicating a possible disease mechanism. Journal of Neuroscience, 24, 2270–2276.PubMed

Taraviras, S., Marcos-Gutierrez, C. V., Durbec, P., Jani, H., Grigoriou, M., Sukumaran, M., Wang, L. C., Hynes, M., Raisman, G., & Pachnis, V. (1999). Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development, 126, 2785–2797.PubMed

Thrasivoulou, C., Soubeyre, V., Ridha, H., Giuliani, D., Giaroni, C., Michael, G. J., Saffrey, M. J., & Cowen, T. (2006). Reactive oxygen species, dietary restriction and neurotrophic factors in age-related loss of myenteric neurons. Aging Cell, 5, 247–257.PubMed

Tucker, P., Beebe, K. L., Burgin, C., Wyatt, D. B., Parker, D. E., Masters, B. K., & Nawar, O. (2004). Paroxetine treatment of depression with posttraumatic stress disorder: Effects on autonomic reactivity and cortisol secretion. Journal of Clinical Psychopharmacology, 24, 131–140.PubMed

Tyler, C. M., & Federoff, H. J. (2006). CNS gene therapy and a nexus of complexity: Systems and biology at a crossroads. Cell Transplantation, 15, 267–273.PubMed

Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003). Diabetic autonomic neuropathy. Diabetes Care, 26, 1553–1579.PubMed

von Boyen, G. B., Reinshagen, M., Steinkamp, M., Adler, G., & Kirsch, J. (2002). Enteric nervous plasticity and development: Dependence on neurotrophic factors. Journal of Gastroenterology, 37, 583–588.

Wakabayashi, K., & Takahashi, H. (1997). Neuropathology of autonomic nervous system in Parkinson’s disease. European Neurology, 38, S2–7.

Wan, R., Camandola, S., & Mattson, M. P. (2003a). Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. Journal of Nutrition, 133, 1921–1929.PubMed

Wan, R., Camandola, S., & Mattson, M. P. (2003b). Intermittent fasting and dietary supplementation with 2-deoxy-d-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB Journal, 17, 1133–1134.PubMed

Wang, X., & Halvorsen, S. W. (1998). Reciprocal regulation of ciliary neurotrophic factor receptors and acetylcholine receptors during synaptogenesis in embryonic chick atria. Journal of Neuroscience, 18, 7372–7380.PubMed

Wang, H., & Zhou, X. F. (2002). Injection of brain-derived neurotrophic factor in the rostral ventrolateral medulla increases arterial blood pressure in anaesthetized rats. Neuroscience, 112, 967–975.PubMed

Williams, B. J., Eriksdotter-Jonhagen, M., & Granholm, A. C. (2006). Nerve growth factor in treatment and pathogenesis of Alzheimer’s disease. Progress in Neurobiology, 80, 114–128.PubMed

Wolf, S. A., Kronenberg, G., Lehmann, K., Blankenship, A., Overall, R., Staufenbiel, M., & Kempermann, G. (2006). Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer’s disease. Biological Psychiatry, 60, 1314–1323.PubMed

Wooten, M. W., Vandenplas, M. L., Seibenhener, M. L., Geetha, T., & Diaz-Meco, M. T. (2001). Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C’s via a src kinase pathway. Molecular Cell Biology, 21, 8414–8427.

Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience, 6, 736–742.PubMed

Yang, B., Slonimsky, J. D., & Birren, S. J. (2002). A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nature Neuroscience, 5, 539–545.PubMed

York, R. D., Molliver, D. C., Grewal, S. S., Stenberg, P. E., McCleskey, E. W., & Stork, P. J. (2000). Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Molecular Cell Biology, 20, 8069–8083.

Zaidi, S. I., Jafri, A., Doggett, T., & Haxhiu, M. A. (2005). Airway-related vagal preganglionic neurons express brain-derived neurotrophic factor and TrkB receptors: Implications for neuronal plasticity. Brain Research, 1044, 133–143.PubMed

Zahn, T. P. (1988). Studies of autonomic psychophysiology and attention in schizophrenia. Schizophrenia Bulletin, 14, 205–208.PubMed

Zhou, X., Nai, Q., Chen, M., Dittus, J. D., Howard, M. J., & Margiotta, J. F. (2004). Brain-derived neurotrophic factor and trkB signaling in parasympathetic neurons: relevance to regulating alpha7-containing nicotinic receptors and synaptic function. Journal of Neuroscience, 24, 4340–4350.PubMed

Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., Timmusk, T., Sipione, S., & Cattaneo, E. (2001). Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science, 293, 493–498.PubMed

Zulli, R., Nicosia, F., Borroni, B., Agosti, C., Prometti, P., Donati, P., De Vecchi, M., Romanelli, G., Grassi, V., & Padovani, A. (2005). QT dispersion and heart rate variability abnormalities in Alzheimer’s disease and in mild cognitive impairment. Journal of the American Geriatrics Society, 53, 2135–2139.PubMed

Titel: Neurotrophic Factors in Autonomic Nervous System Plasticity and Dysfunction
verfasst von: Mark P. Mattson
Ruiqian Wan
Publikationsdatum: 01.09.2008
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 3/2008
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-007-8021-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Autonomic Control of the Aging Heart

Perturbed Autonomic Nervous System Function in Metabolic Syndrome

The Molecular Basis of Familial Dysautonomia: Overview, New Discoveries and Implications for Directed Therapies

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer’s Disease

The Sympathetic Nervous System and Pain